Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on March 13, 2022 19:26 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 266653556 series 2740117
Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?
Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians
References
Frye BC, Meiss F, von Bubnoff D, Zissel G, Müller-Quernheim J. Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. N Engl J Med. 2020;382(26):2573-2574. doi:10.1056/NEJMc2000343
Benitez R, Delgado-Maroto V, Caro M, et al. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses. J Immunol. 2018;200(11):3697-3710. doi:10.4049/jimmunol.1800122 Not Medical Advice or Opinion246 episodes